Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 2 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
FOXK1 promotes nonalcoholic fatty liver disease by mediating mTORC1-dependent inhibition of hepatic fatty acid oxidation.
Cell Rep. 2023 May 30;42(5):112530. doi: 10.1016/j.celrep.2023.112530. Epub 2023 May 18.
Cell Rep. 2023.
PMID: 37209098
Free article.
Phosphorylation of PBX2, a novel downstream target of mTORC1, is determined by GSK3 and PP1.
Wada R, Fujinuma S, Nakatsumi H, Matsumoto M, Nakayama KI.
Wada R, et al. Among authors: fujinuma s.
J Biochem. 2023 Feb 3;173(2):129-138. doi: 10.1093/jb/mvac094.
J Biochem. 2023.
PMID: 36477205
Item in Clipboard
Identification of effective CCR2 inhibitors for cancer therapy using humanized mice.
Sugiyama S, Yumimoto K, Fujinuma S, Nakayama KI.
Sugiyama S, et al. Among authors: fujinuma s.
J Biochem. 2024 Feb 25;175(2):195-204. doi: 10.1093/jb/mvad086.
J Biochem. 2024.
PMID: 37947138
Item in Clipboard
Cite
Cite